Effects of the 5-HT(2C/2B) antagonist SB 206553 on hyperactivity induced by cocaine

Neuropsychopharmacology

Volumn 20, Issue 6, 1999, Pages 556-564

  McCreary, Andrew C ^a   Cunningham, Kathryn A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

5 HT(2B); 5 HT(2C); Cocaine; Hyperactivity; SB 206553; Serotonin

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; COCAINE; RECEPTOR SUBTYPE; SEROTONIN 2 RECEPTOR; INDOLE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HYPERKINESIA; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; COCAINE; HYPERKINESIS; INDOLES; MALE; MOTOR ACTIVITY; NEURONS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0033137332     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00087-6     Document Type: Article

References (42)

1. Amalric M, Koob GF (1993): Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. In Arbthnott GW, Emson PC (eds), Progress in Brain Research. New York, Elsevier Science, 99:209-226.
2. 2A antagonist MDL 100907 on midbrain dopamine (DA) neurons in rats. An electrophysiological study Soc Neurosci Abstr. 22:1996;1323.
3. Berman M.H., Quock R.M., Blankenship J. Interaction of dopaminergic and serotonergic mechanisms in cocaine induced behavioral effects in rats. Res Comm Subst Abuse. 3:1982;141-155.
4. 2C receptors. J Pharmacol Exp Ther. 274:1995;1414-1424.
5. 1 receptors in nucleus accumbens Psychopharmacol. 115:1994;110-114.
6. 1C receptors in rat choroid plexus. Brain Res. 400:1987;396-398.
7. Cunningham K.A., Callahan P.M. Neurobehavioral pharmacology of cocaine. Role for serotonin in its locomotor and discriminative stimulus effects Erinoff L., Brown R.M. Neurobiological Models for Evaluating Mechanisms Underlying Cocaine Addiction. 1994;40-66 US Government Printing Office, Washington, DC.
8. de Wit H., Wise R.A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol. 31:1977;195-203.
9. 2C agonists induce c-FOS expression in different neuronal populations in the rat CNS. J Psychopharmacol. 10:1996;186.
10. Duxon M.S., Flanigan T.P., Reavley A.C., Baxter G.S., Blackburn T.P., Fone K.C.F. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neurosci. 76:1997;323-329. a.
11. 2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. Neuropharmacol. 36:1997;601-608. b.
12. 2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol. 384:1997;233-247.
13. Einhorn L.C., Johansen P.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system. Studies in the ventral tegmental area J Neurosci. 8:1988;100-112.
14. 2C receptors in the shell of the nucleus accumbens modulate cocaine-induced hyperactivity. Soc Neurosci Abstr. 24:1998;2171.
15. 2C/2B receptor antagonist with improved affinity, selectivity, and oral activity J Med Chem. 38:1995;2524-2530.
16. Herges S., Taylor D.A. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacol Biochem Behav. 59:1998;595-611.
17. 1C receptor mRNA in adult rat brain. FEBS Lett. 247:1989;453-462.
18. Howell L.L., Byrd L.D. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther. 275:1995;1551-1559.
19. Hoyer D., Martin G. 5-HT receptor classification and nomenclature. Towards a harmonization with the human genome Neuropharmacol. 36:1997;419-428.
20. Kelland M.D., Freeman A.S., Chiodo L.A. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J Pharmacol Exp Ther. 253:1990;803-811.
21. 1C receptors and their therapeutic relevance. Curr Opin Invest Drugs. 2:1993;317-362.
22. 2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacol. 36:1997;233-239.
23. 2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol. 117:1996;427-434.
24. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther. 199:1976;647-661.
25. 2C receptors inhibit the activity of mesocortical and mesolimbic dopaminergic pathways. A combined dialysis and electrophysiological analysis Soc Neurosci Abst. 23:1997;975.
26. Lucki I., Ward H.R., Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther. 249:1989;155-164.
27. 1 receptor antagonism by SCH 23390 prevents expression of conditioned sensitization following repeated administration of cocaine Neuropharmacol. 32:1993;387-391.
28. Meert T.F., Janssen P.A.J. Ritanserin, a new therapeutic approach for drug abuse. Part 2. Effects on cocaine Drug Dev Res. 25:1992;39-53.
29. 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution Neurosci. 35:1990;577-591.
30. Nader M.A., Barrett J.E. Effects of chlordiazepoxide, buspirone, and serotonin receptor agonists and antagonists on responses of squirrel monkeys maintained under second-order schedules of intramuscular cocaine injection of food presentation. Drug Dev Res. 20:1990;5-17.
31. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
32. Peltier R.L., Emmett-Oglesby M.W., Thomas W.H., Schenk S. Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine. Pharmacol Biochem Behav. 48:1994;473-478.
33. Prisco S., Esposito E. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br J Pharmacol. 116:1995;1923-1931.
34. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area. An electrophysiological study in vivo J Pharmacol Exp Ther. 271:1994;83-90.
35. 3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur J Pharmacol. 186:1990;327-330.
36. Scheel-Kruger J., Braestrup C., Nielson M., Golembiowska K., Mogilnicka E. Cocaine. Discussion of the role of dopamine in the biochemical actions Ellinwood Jr E.H., Kilbey M.M. Cocaine and Other Stimulants. 1977;373-407 Plenum Press, New York.
37. 2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody. Effect of 5,7-dihydroxytryptamine Synapse. 27:1997;45-56.
38. 3 receptors Soc Neurosci Abstr. 23:1997;2326.
39. 2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J Neurosci. 16:1996;7566-7573.
40. 2F receptor. Mol Pharmacol. 43:1993;419-426.
41. Walsh S.L., Cunningham K.A. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacol. 130:1997;41-58.
42. White F.J., Joshi A., Koeltzow T.E., Hu X.T. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacol. 18:1998;26-40.